Raymond James Trust’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,074
Closed -$217K – 1220
2023
Q1
$217K Buy
+1,074
New +$172K 0.01% 1031
2022
Q3
– Sell
-1,646
Closed -$291K – 1128
2022
Q2
$291K Sell
1,646
-7
-0.4% -$1.01K 0.01% 821
2022
Q1
$238K Hold
1,653
– – 0.01% 999
2021
Q4
$256K Sell
1,653
-732
-31% -$123K 0.01% 976
2021
Q3
$405K Sell
2,385
-26
-1% -$4.05K 0.01% 706
2021
Q2
$381K Sell
2,411
-1
-0% -$149 0.01% 743
2021
Q1
$335K Buy
+2,412
New +$389K 0.01% 779
2020
Q4
– Sell
-1,232
Closed -$241K – 1072
2020
Q3
$241K Buy
+1,232
New +$206K 0.01% 798

Other funds holding SGEN

Raymond James Trust's SGEN Position: Q2 2023 in Review

Raymond James Trust sold out of Seagen Inc. Common Stock (SGEN) in Q2 2023, closing a stake of 1,074 shares — an estimated $217K sold.

Raymond James Trust first reported a position in SGEN in Q3 2020 and held it in 8 quarters. The position peaked at $405K in Q3 2021. 594 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

  • Raymond James Trust reported no remaining Seagen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Raymond James Trust sold 1,074 Seagen Inc. Common Stock shares in Q2 2023, an estimated $217K.
  • Raymond James Trust first reported a position in Seagen Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Raymond James Trust's Seagen Inc. Common Stock position peaked at $405K in Q3 2021.
  • 594 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on Raymond James Trust's 13F filing for Q2 2023, filed 15 Aug 2023.